A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer
Recruiting · NCT07513311 · Interventional (participants receive a specific treatment) · Lead sponsor: Massachusetts General Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Enhanced Usual CareRESTORE
What this trial is about
The purpose of this study is to explore the feasibility and acceptability of a nurse-led, coping, and supportive care intervention for patients with triple-negative breast cancer. The intervention aims to improve psychosocial outcomes in patients with triple-negative breast cancer (e.g., quality of life (QOL), anxiety, fear of cancer recurrence (FCR)).
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of stage 1-3 triple-negative breast cancer
- Age ≥ to 18 years
- Between one and 12 months post curative therapy
- Reporting distress at least 4/10 on a one-item screener
- Ability to read and respond in English or Spanish
Exclusion criteria
- Patients with stage 4 cancer
- Patients with impaired cognition or serious mental illness that would preclude participation in study procedures
Where it is running
1 location listed across 1 US state.
- Massachusetts General Hospital - Boston, Massachusetts, United States